SWOG S1602

Primary Category:

Treatment Protocols

Disease Category:

Bladder, Genitourinary


Temporarily Closed

A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-Naïve High-Grade Non-Muscle Invasive Bladder Cancer


Eligible for screening study DCP 001

S1602 is temporarily closed to accrual, effective immediately, 08/28/19. Because the study has not been revised to outline the change in the randomization scheme, it is not ethical to continue patient randomization, due to the drug supply issue for BCG Tokyo-172.